Literature DB >> 2005102

Sites of stromelysin cleavage in collagen types II, IX, X, and XI of cartilage.

J J Wu1, M W Lark, L E Chun, D R Eyre.   

Abstract

Human recombinant stromelysin-1 was shown to cleave four types of collagen (types II, IX, X, and XI) prepared from bovine and rat cartilages at specific sites. Stromelysin-1 cleaved salt-soluble native molecules of type IX collagen into two main triple-helical fragments, COL1 and COL2,3. Protein microsequencing identified the exact cleavage sites in the NC2 domain of all three chains, alpha 1(IX), alpha 2(IX), and alpha 3(IX). Stromelysin-1 also acted as a "telopeptidase," in that it efficiently clipped intact molecules of types II and XI collagens at sites just inside their terminal cross-linking hydroxylysine residues. Native molecules of type X collagen were cleaved by stromelysin-1 within their triple helical domains at a COOH-terminal site that reduced the alpha 1(X) chain size by 10 kDa. These findings suggest an important role for stromelysin in the turnover and remodeling of the collagenous matrix of cartilage both normally and in degenerative joint disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2005102

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

Review 1.  Articular cartilage chondrons: form, function and failure.

Authors:  C A Poole
Journal:  J Anat       Date:  1997-07       Impact factor: 2.610

2.  Moderate joint loading reduces degenerative actions of matrix metalloproteinases in the articular cartilage of mouse ulnae.

Authors:  Hui B Sun; Liming Zhao; Shigeo Tanaka; Hiroki Yokota
Journal:  Connect Tissue Res       Date:  2011-12-07       Impact factor: 3.417

Review 3.  MMPs and TIMPs--an historical perspective.

Authors:  J Frederick Woessner
Journal:  Mol Biotechnol       Date:  2002-09       Impact factor: 2.695

4.  The NC2 domain of collagen IX provides chain selection and heterotrimerization.

Authors:  Sergei P Boudko; Keith D Zientek; Jesse Vance; Jessica L Hacker; Jürgen Engel; Hans Peter Bächinger
Journal:  J Biol Chem       Date:  2010-05-27       Impact factor: 5.157

5.  Proteolytic mechanisms of cartilage breakdown: a target for arthritis therapy?

Authors:  D J Buttle; H Bramwell; A P Hollander
Journal:  Clin Mol Pathol       Date:  1995-08

6.  Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.

Authors:  M W Lark; E K Bayne; J Flanagan; C F Harper; L A Hoerrner; N I Hutchinson; I I Singer; S A Donatelli; J R Weidner; H R Williams; R A Mumford; L S Lohmander
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

7.  Effects of perfusion and dynamic loading on human neocartilage formation in alginate hydrogels.

Authors:  Shawn P Grogan; Sujata Sovani; Chantal Pauli; Jianfen Chen; Andreas Hartmann; Clifford W Colwell; Martin K Lotz; Darryl D D'Lima
Journal:  Tissue Eng Part A       Date:  2012-06-12       Impact factor: 3.845

8.  Potential of Raloxifene in reversing osteoarthritis-like alterations in rat chondrocytes: an in vitro model study.

Authors:  Aysegul Kavas; Seda Tuncay Cagatay; Sreeparna Banerjee; Dilek Keskin; Aysen Tezcaner
Journal:  J Biosci       Date:  2013-03       Impact factor: 1.826

Review 9.  A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention.

Authors:  Allen Y Chen; Yi Charlie Chen
Journal:  Food Chem       Date:  2012-12-28       Impact factor: 7.514

10.  Articular cartilage superficial zone collagen birefringence reduced and cartilage thickness increased before surface fibrillation in experimental osteoarthritis.

Authors:  H E Panula; M M Hyttinen; J P Arokoski; T K Långsjö; A Pelttari; I Kiviranta; H J Helminen
Journal:  Ann Rheum Dis       Date:  1998-04       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.